Developments towards on artificial kidney

Expert Review of Medical Devices

Volumn 3, Issue 2, 2006, Pages 155-165

  Fissell, William H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

BioMEMS; Dialysis; Nanotechnology; Renal failure; Tissue engineering

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; DROTRECOGIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE KIDNEY FAILURE; ADOPTIVE IMMUNOTHERAPY; ARTIFICIAL KIDNEY; BIOARTIFICIAL KIDNEY; BIOARTIFICIAL ORGAN; BIOREACTOR; CLINICAL TRIAL; DIALYSIS; ELECTRONICS; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MATHEMATICAL COMPUTING; MEDICAL TECHNOLOGY; MICROFLUIDICS; NANOTECHNOLOGY; NONHUMAN; RENAL ASSIST DEVICE; RENAL REPLACEMENT THERAPY; REVIEW; SEPTIC SHOCK; TISSUE ENGINEERING; UNITED STATES;

BIOARTIFICIAL ORGANS; CLINICAL TRIALS; EQUIPMENT DESIGN; HUMANS; KIDNEY FAILURE; KIDNEY, ARTIFICIAL; RENAL DIALYSIS; TISSUE ENGINEERING;

EID: 33646176572     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.2.155     Document Type: Review

References (34)

1. US Renal Data System. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, MD, USA (2002).
2. Neilson EG, Hull AR, Wish JB, Neylan JF, Sherman D, Suki WN. The Ad Hoc Committee Report on estimating the future workforce and training requirements for nephrology. J. Am. Soc. Nephrol. 8(5 Suppl. 9), S1-S4 (1997).
3. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 1725-1730 (1999).
4. 4 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association; Ann Arbor, MI, USA (2004).
5. Salonen T, Reina T, Oksa H, Sintonen H, Pasternack A. Cost analysis of renal replacement therapies in Finland. Am. J. Kidney Dis. 42, 1228-1238 (2003).
6. Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J. Vasc. Surg. 38, 1005-1011 (2003).
7. McKay SM, Funke AJ, Buffington DA, Humes HD. Tissue engineering of a bioartificial renal tubule. ASAIO J. 44, 179-183 (1998).
8. Humes HD, McKay SM, Funke AJ, Buffington DA. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int. 55, 2503-2514 (1999).
9. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat. Biotechnol. 17, 451-455 (1999).
10. Humes HD, Fissell WH, Weitzel WF et al. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am. J. Kidney Dis. 39, 1078-1087 (2002).
11. Fissell WH, Dyke DB, Weitzel WF et al. Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals. Blood Purif. 20, 55-60 (2002).
12. Fissell WH, Lou L, Abrishami A, Buffington DA, Humes HD. Bioartificial kidney ameliorates gram-negative bacteria induced septic shock in uremic animals. J. Am. Soc. Nephrol. 14, 454-461 (2003).
13. Humes HD, Buffington DA, Lou L et al. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit. Care Med. 31, 2421-2428 (2003).
14. Humes HD, Weitzel WF, Bartlett RH et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 66(4), 1578-1588 (2004).
15. Tumlin J, Wali R, Brennan K, Humes HD. Effect of the renal assist device (RAD) on mortality of dialysis-dependent acute renal failure: a randomized, open-labeled, mulitcenter, Phase II trial. J. Am. Soc. Nephrol, 16, 46A (2005).
16. Bernard GR, Vincent J-L, Laterre P-F et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699-709 (2001).
17. Annane D, Sébille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288, 862-871 (2002).
18. Gura V, Beizai M, Ezon C, Polaschegg H-D. Continuous renal replacement therapy for end-stage renal disease. Contrib. Nephrol. 149, 325-333 (2005).
19. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347, 2010-2019 (2002).
20. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int. 78(Suppl.), S206-S211 (2001).
21. Vlagopoulos PT, Sarnak MJ. Traditional and nontraditional cardiovascular risk factors in chronic kidney disease. Med. Clin. North Am. 89(3), 587-611 (2005).
22. Weiner DE, Tighiouart H, Stark PC et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am. J. Kidney Dis. 44(2), 198-206 (2004).
23. Periyasamy SM, Chen J, Cooney D et al. Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Kidney Int. 60, 2367-2376 (2001).
24. Leonard EF, West AC, Shapley NC, Larsen MU. Dialysis without membranes: how and why? Blood Purif. 22, 92-100 (2004).
25. Leonard EF, Cortell S, Vitale NG. Membraneless dialysis - is it possible? Contrib. Nephrol. 149, 343-353 (2005).
26. Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R. The human nephron filter: toward a continuously functioning, implantable artificial nephron. Blood Purif. 23, 269-274 (2005).
27. Venkatachalam MA, Kriz W. Anatomy. In: Heptinstall's Pathology of the Kidney (Fifth Edition). Jennette JC, Olson JL, Schwartz MM, Silva FG (Eds), Lippincott-Raven, PA, USA, 25-26 (1998).
28. Deen WM, Satvat B, Jamieson JM. Theoretical model for glomerular filtration of charged solutes. Am. J. Physiol. 238, F126-F139 (1980).
29. Smithies O. Why the kidney glomerulus does not clog: a gel permeation/ diffusion hypothesis of renal function. Proc. Nat. Acad. Sci. 100, 4108-4113 (2003).
30. Ruotsalainen V, Ljungberg P, Wartiovaara J et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc. Nat. Acad. Sci. 96(14), 7962-7967 (1999).
31. Zeman L, Zydney A. Microfiltration and Ultrafiltration. Marcel Dekker, NY, USA (1996).
32. Dunleavy M. Polymeric membranes. A review of applications. Med. Device Technol. 7, 18-21 (1996).
33. Bjornson A, Moses J, Ingemansson A, Haraldsson B, Sorensson J. Primary glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am. J. Physiol. Renal. Physiol. 288(4), F748-F756 (2005).
34. Fissell WH, Humes HD, Roy S, Fleischman A. Initial characterization of a nanoengineered ultrafiltration membrane. J. Am. Soc. Nephrol. 13, 602A (2002).